Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia
- 15 June 1993
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 71 (16), 1408-1414
- https://doi.org/10.1016/0002-9149(93)90601-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Long-term safety and efficacy profile of simvastatinThe American Journal of Cardiology, 1991
- Efficacy and safety of pravastatin in patients with primary hypercholesterolemia: II. Once-daily versus twice-daily dosingAtherosclerosis, 1990
- Efficacy and safety of pravastatin in patients with primary hypercholesterolemia: I. A dose-response studyAtherosclerosis, 1990
- Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial HypercholesterolemiaArchives of Internal Medicine, 1990
- Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoBiochemical and Biophysical Research Communications, 1989
- Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects A double blind testAtherosclerosis, 1988
- Mechanism of Action and Biological Profile of HMG CoA Reductase InhibitorsDrugs, 1988
- A scale for the estimation of sleep problems in clinical researchJournal of Clinical Epidemiology, 1988
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- The Wilcoxon, Ties, and the ComputerJournal of the American Statistical Association, 1966